p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction

p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction

Background Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of patients with heart failure. Clinically, HFpEF prevalence shows age and gender biases. Although the majority of patients with HFpEF are elderly, there is an emergence of young patients with HFpEF. A better understa...

書誌詳細
主要な著者:	Xiaonan Chen, Hao Lin, Weiyao Xiong, Jianan Pan, Shuying Huang, Shan Xu, Shufang He, Ming Lei, Alex Chia Yu Chang, Huili Zhang
フォーマット:	論文
言語:	English
出版事項:	Wiley 2022-06-01
シリーズ:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主題:	aging HFpEF mitochondrial homeostasis p53 activation
オンライン･アクセス:	https://www.ahajournals.org/doi/10.1161/JAHA.121.024582

類似資料

The role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction
著者:: Becker Al-Khayatt, 等
出版事項: (2024-05-01)

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
著者:: Satyam Sarma, 等
出版事項: (2020-11-01)

iNOS contributes to heart failure with preserved ejection fraction through mitochondrial dysfunction and Akt S-nitrosylation
著者:: Yongzheng Guo, 等
出版事項: (2023-01-01)

Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial
著者:: Bin Dong, 等
出版事項: (2022-11-01)

Murine Models of Heart Failure With Preserved Ejection Fraction
著者:: Maria Valero-Muñoz, PhD, 等
出版事項: (2017-12-01)

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
著者:: Clement Lau, 等
出版事項: (2022-07-01)

Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction
著者:: Gabrielle Fusco‐Allison, 等
出版事項: (2021-10-01)

Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
著者:: Ahmed Hamam, 等
出版事項: (2022-12-01)

Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
著者:: Yohei Sotomi, 等
出版事項: (2021-06-01)

Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
著者:: Elisabeth A. Jalink, 等
出版事項: (2024-01-01)

Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial
著者:: Kramer J. Wahlberg, 等
出版事項: (2024-01-01)

Diagnostic signature for heart failure with preserved ejection fraction (HFpEF): a machine learning approach using multi-modality electronic health record data
著者:: Nazli Farajidavar, 等
出版事項: (2022-12-01)

Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study
著者:: Ravi V. Shah, 等
出版事項: (2023-11-01)

Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
著者:: José M. Inácio, 等
出版事項: (2023-07-01)

Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature
著者:: Alberto Palazzuoli, 等
出版事項: (2023-01-01)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
著者:: Mariëlle Scheffer, 等
出版事項: (2020-12-01)

Right Ventricular‐Vascular Uncoupling Predicts Pulmonary Hypertension in Clinically Diagnosed Heart Failure With Preserved Ejection Fraction
著者:: Zheng‐Wei Chen, 等
出版事項: (2024-01-01)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis
著者:: Arjun K. Pandey, 等
出版事項: (2022-04-01)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
著者:: Zhen Hui Peh, 等
出版事項: (2023-06-01)

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
著者:: Mark Sweeney, 等
出版事項: (2020-09-01)

The clinical relevance of quality of life in heart failure patients with preserved ejection fraction
著者:: Masahiro Seo, 等
出版事項: (2023-04-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): A Case Report
著者:: Amanda Halimi, 等
出版事項: (2021-09-01)

Myths and Facts About Heart Failure with Preserved Ejection Fraction: Risk Factors, Longevity, Potential Pharmacological and Exercise Interventions
著者:: Chung-Lieh Hung, 等
出版事項: (2013-03-01)

Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta‐analysis
著者:: Domenico D'Amario, 等
出版事項: (2024-08-01)

Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction
著者:: Xiao Wang, 等
出版事項: (2024-11-01)

Validation of heart failure algorithm for diagnosing heart failure with preserved ejection fraction: a meta‐analysis
著者:: Shu Li, 等
出版事項: (2023-08-01)

Prognostic value of Growth differentiation factors 15 in Acute heart failure patients with preserved ejection fraction
著者:: Dan Yin, 等
出版事項: (2023-04-01)

Large Animal Models of Heart Failure: Reduced vs. Preserved Ejection Fraction
著者:: Christopher J. Charles, 等
出版事項: (2020-10-01)

Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction
著者:: Bence Hegyi, 等
出版事項: (2022-12-01)

Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
著者:: Heidi Budde, 等
出版事項: (2022-07-01)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
著者:: Jenni Huusko, 等
出版事項: (2020-06-01)

The Prognostic Value of Anemia in Patients with Preserved, Mildly Reduced and Recovered Ejection Fraction
著者:: Anita Pintér, 等
出版事項: (2022-02-01)

Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction
著者:: Stephanie J. Rowe, BBiomed, MD, 等
出版事項: (2025-01-01)

Sex differences in mortality and hospitalization in heart failure with preserved and mid-range ejection fraction: a systematic review and meta-analysis of cohort studies
著者:: You Deng, 等
出版事項: (2024-01-01)

Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum
著者:: Karolina Andrzejczyk, 等
出版事項: (2024-06-01)

Independent predictors of developing pulmonary hypertension in heart failure with reduced versus preserved ejection fraction
著者:: Alaa Roushdy, 等
出版事項: (2017-07-01)

Age‐stratified profiles and outcomes of patients with heart failure with preserved ejection fraction
著者:: Shinsuke Yamanaka, 等
出版事項: (2024-08-01)

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
著者:: Kyle B. LaPenna, 等
出版事項: (2021-03-01)

Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON‐HF Proteomic Substudy
著者:: Natasha L. Patel‐Murray, 等
出版事項: (2024-07-01)

Incidence and risk factors of heart failure with preserved ejection fraction in elderly patients with hypertension
著者:: Min Chen, 等
出版事項: (2024-12-01)